In patients with NAFLD adiponectin concentrations are decreased compared to normal subjects [52,53], despite higher lipolysis and fatty acid concentrations associated with increased hepatic and systemic fatty acid oxidation. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.